3-31533139-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 2P and 11B. PM2BP4_ModerateBP6_Very_StrongBP7
The NM_178862.3(STT3B):c.141C>T(p.Gly47Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000196 in 1,295,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000087 ( 0 hom. )
Consequence
STT3B
NM_178862.3 synonymous
NM_178862.3 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 0.934
Genes affected
STT3B (HGNC:30611): (STT3 oligosaccharyltransferase complex catalytic subunit B) The protein encoded by this gene is a catalytic subunit of a protein complex that transfers oligosaccharides onto asparagine residues. Defects in this gene are a cause of congenital disorder of glycosylation Ix (CDG1X). [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 3-31533139-C-T is Benign according to our data. Variant chr3-31533139-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 513479.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.934 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STT3B | NM_178862.3 | c.141C>T | p.Gly47Gly | synonymous_variant | 1/16 | ENST00000295770.4 | NP_849193.1 | |
STT3B | XM_011533465.2 | c.141C>T | p.Gly47Gly | synonymous_variant | 1/10 | XP_011531767.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STT3B | ENST00000295770.4 | c.141C>T | p.Gly47Gly | synonymous_variant | 1/16 | 1 | NM_178862.3 | ENSP00000295770.2 | ||
STT3B | ENST00000453168.5 | n.502C>T | non_coding_transcript_exon_variant | 1/10 | 1 | |||||
STT3B | ENST00000423527.5 | n.168C>T | non_coding_transcript_exon_variant | 1/10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00102 AC: 154AN: 151228Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
154
AN:
151228
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000193 AC: 3AN: 15558Hom.: 0 AF XY: 0.000119 AC XY: 1AN XY: 8372
GnomAD3 exomes
AF:
AC:
3
AN:
15558
Hom.:
AF XY:
AC XY:
1
AN XY:
8372
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000874 AC: 100AN: 1144632Hom.: 0 Cov.: 32 AF XY: 0.0000834 AC XY: 46AN XY: 551856
GnomAD4 exome
AF:
AC:
100
AN:
1144632
Hom.:
Cov.:
32
AF XY:
AC XY:
46
AN XY:
551856
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00102 AC: 154AN: 151334Hom.: 0 Cov.: 32 AF XY: 0.000933 AC XY: 69AN XY: 73938
GnomAD4 genome
AF:
AC:
154
AN:
151334
Hom.:
Cov.:
32
AF XY:
AC XY:
69
AN XY:
73938
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 01, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
STT3B-congenital disorder of glycosylation Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 26, 2023 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | STT3B: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at